3rd Quarter - Report

ELI LILLY AND COMPANY for ELI LILLY AND COMPANY

Firm
Client
Income
—
Expenses
$3,340,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Finland (IP), Belgium (pricing), Czech republic (market access & pricing reform), Finland (IP), Germany (pricing), Italy (pricing), Norway (market access), Poland (market access), Switzerland (parallel trade), United Kingdom (pricing), Korea Free Trade Agreement, Japan (pricing), China (pricing & regulatory), ASEAN (regulatory harmonization), Thailand (CLs), Philippines (price), Latin America Free Trade, Canada (S 242), Canada (access), Mexico (access), Brazil (access), Algeria & Tunisia (access), Saudia Arabia (access), Argentina (access)

LobbyistCovered position, as disclosed
KERN BRIGGS —
HARRISON C COOK —
DAVID TALBOT —

Contacted: State, Dept of (DOS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Natl Security Council (NSC); SENATE; U.S. Trade Representative (USTR)

Copyright/Patent/Trademark CPT

HR 1908, S 1145, HR 5629, HR 1956, S 623, Finland. Norway IP, Portugal IP, Switzerland (parallel trade), Japan (regulatory), Korea FTA (regulatory & IP), China (IP), ASEAN (regulatory harmonization), Thailand (CLs), Phillippines (anti-IP), Canada IP, Mexico IP, Brazil IP, Algeria & Tunisia IP, Egypt IP, Saudi Arabia IP, Ecuador IP, Argentina IP, Chile IP, Russia IP

LobbyistCovered position, as disclosed
BRUCE ARTIM —
KERN BRIGGS —
HARRISON C COOK —
DAVID TALBOT —

Contacted: State, Dept of (DOS); Health & Human Services, Dept of (HHS); Natl Security Council (NSC); SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Commerce, Dept of (DOC)

Bills named: H.R. 1956 (110th), H.R. 5629 (110th), H.R. 1908 (110th)

Health Issues HCR

Healthcare Reform in Belgium, Germany, Italy, United Kingdom, South Africa, and MDR-TB, Comparative Effectiveness (S 3408), Food & Drug Safety (HR 3610), Biosimilars (HR 5629), Transparency (S 2029 & HR 5605)

LobbyistCovered position, as disclosed
JAY BONITT —
KERN BRIGGS —
SEAN DONOHUE —
DESIREE FILIPPONE —
SUZANNE SIMALA —
SONYA SOTAK ELLING —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC); Natl Security Council (NSC); Health & Human Services, Dept of (HHS); State, Dept of (DOS)

Bills named: H.R. 3610 (110th), H.R. 5629 (110th), H.R. 5605 (110th)

Medicare/Medicaid MMM

Waxman Medicare Part D non-interference,

LobbyistCovered position, as disclosed
JAY BONITT —
JESSIE BRAIRTON —
JESSE PRICE —

Contacted: SENATE; State, Dept of (DOS); Natl Security Council (NSC); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS)

Consumer Issues/Safety/Products CSP

China (counterfeiting & regulatory), ASEAN (regulatory harmonization),

LobbyistCovered position, as disclosed
HARRISON C COOK —

Contacted: SENATE; Natl Security Council (NSC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); State, Dept of (DOS); U.S. Trade Representative (USTR)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.